Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Revenue (2016 - 2017)

Bone Biologics (BBLG) has disclosed Revenue for 2 consecutive years, with -$957062.0 as the latest value for Q2 2017.

  • On a quarterly basis, Revenue fell 165.92% to -$957062.0 in Q2 2017 year-over-year; TTM through Dec 2017 was -$1.7 million, a 66.58% decrease, with the full-year FY2025 number at $125951.0, up 18.0% from a year prior.
  • Revenue was -$957062.0 for Q2 2017 at Bone Biologics, down from -$762352.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of -$310089.0 in Q1 2016 to a low of -$957062.0 in Q2 2017.